Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05303753 · ClinicalTrials.gov registry record · NA
Protein-Prebiotic Wellbeing Study
A NA study of Quality of Life and Digestive Health, sponsored by Arizona State University.
- Completed
- Registry status
- NA
- Development phase
- 98
- Enrollment target
- 1
- Study location
NCT05303753: Completed NA study of Quality of Life and Digestive Health, sponsored by Arizona State University.
NCT05303753 is a NA study of Quality of Life and Digestive Health that has completed, run by Arizona State University. The registered enrollment target is 98 participants, below the 452-participant average among 107 other Quality of Life trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05303753, a NA study of Quality of Life and Digestive Health, has completed, sponsored by Arizona State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 98 participants
- Enrollment target
- 1
- Study location
Study Summary
Healthy participants with self-reported GI complaints will consume the protein supplement that they normally use for recovery purposes after exercise during a 3-week baseline period, followed by a 3-week intervention period in which they maintain usage of their product, but replace a part of this product with a fermented dairy protein with prebiotic fiber. In addition, a group of healthy participants without self-reported GI complaints will serve as a reference group by consuming the protein supplement that they normally use for recovery purposes after exercise during a 3-week period.
Primary Outcome
Gastrointestinal Symptoms Rating Scores (GSRS-score: Average of all 5 sub-scores)
Conditions Studied
Interventions
- OTHER fermented dairy protein with prebiotic fiber
Study Locations (1)
Arizona
- Arizona State University - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2022-01-26 |
| Est. Completion | 2022-07-11 |
| Phase | NA |
What the finished NCT05303753 record still lists
NCT05303753 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 98 participants, a relatively small participant target, below the 452-participant average among 107 other Quality of Life trials with a reported enrollment target (78% lower).
The record links to 2 conditions, with Quality of Life appearing as the primary indexed condition, and to 1 intervention - of which fermented dairy protein with prebiotic fiber is the first listed.
NCT05303753 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT05303753 about?
NCT05303753 is a clinical study titled "Protein-Prebiotic Wellbeing Study". Healthy participants with self-reported GI complaints will consume the protein supplement that they normally use for recovery purposes after exercise during a 3-week baseline period, followed by a 3-week intervention period in which they maintain usage of their product, but replace a part of this pr...
What is the current status of trial NCT05303753?
This trial is currently completed. It is a NA study. The enrollment target is 98 participants. The study started on 2022-01-26. Estimated completion is 2022-07-11.
What conditions does trial NCT05303753 study?
This clinical trial studies the following conditions: Quality of Life, Digestive Health.
What interventions are being tested in trial NCT05303753?
The interventions under investigation include: fermented dairy protein with prebiotic fiber (OTHER).
Who is sponsoring clinical trial NCT05303753?
This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05303753 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Quality of Life
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05303753's enrollment target sits among peer trials
98 52nd of 107 higher than 56 of 107 other Quality of Life trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Quality of Life trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Development of a Multi-sensory Rehabilitation Program for People With Ultra Low Vision
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
-
Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
RECRUITING · NA
-
Asthma Intervention With Residential Ventilation and Air Cleaner (AIRVAC) Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02926729 · 98 participants · NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- NCT03382977 · 98 participants · Phase 1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- NCT04577014 · 98 participants · Phase 1
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- NCT04817618 · 98 participants · Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI